Welcome to our dedicated page for abrdn World Healthcare Fund SEC filings (Ticker: THW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on abrdn World Healthcare Fund's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into abrdn World Healthcare Fund's regulatory disclosures and financial reporting.
abrdn World Healthcare Fund director Mahai Chris LaVictoire has filed an initial ownership report on Form 3. This filing establishes LaVictoire as a reporting insider of the fund but does not list any share holdings or report any buy, sell, or other transactions.
abrdn World Healthcare Fund filed a preliminary prospectus registering up to $128,000,000 of common shares, preferred shares, notes and subscription rights under a shelf registration to be sold from time to time. The Fund is a diversified, closed-end management investment company focused on healthcare companies and intends to invest at least 80% of its Managed Assets in the healthcare industry.
The prospectus discloses key terms and policies: the Fund’s NAV was $12.72 and the last reported NYSE sale price was $12.80 (a 0.63% premium) as of May 6, 2026; the Fund has 40,363,833.60 common shares outstanding as of that date; it targets monthly distributions of $0.1167 per share; and it currently uses a $120,000,000 revolving credit facility. The Adviser fee is 1.00% of managed assets and total annual expenses are shown as 3.00%.
abrdn World Healthcare Fund reported a new insider with no share ownership. A Form 3 filing shows an individual serving as a Vice President of the fund and therefore an officer of the issuer. The filing states that no securities of abrdn World Healthcare Fund are beneficially owned by this reporting person, and both the non-derivative and derivative ownership tables are blank. The document also includes a power of attorney authorizing the signatory, dated 12/19/2025, and identifies the event date triggering the report as 12/09/2025.